Table 1.
Corporal weight gain and relation between rat liver and final corporal weight (standard deviation on parenthesis).
| Group | Initial body weight (g) | Final body weight (g) | Body weight gain (g) | Liver weight (g) |
Liver weight/final body weight (%) |
|---|---|---|---|---|---|
| I | 176.39 (12.23) | 212.23 (13.42) | 35.84 (3.25)b | 3.49 (0.80)a | 1.64 (0.22)a |
| II | 189.24 (13.88) | 194.70 (17.40) | 5.46 (1.99)a | 4.85 (0.86)b | 2.49 (0.51)b |
| III | 175.29 (12.26) | 214.87 (25.21) | 39.58 (4.52)b | 3.41 (0.75)a | 1.59 (0.29)a |
| IV | 181.36 (12.54) | 223.47 (13.15) | 42.11 (4.12)b.c | 3.86 (0.65)a,b | 1.72 (0.35)a |
| V | 191.86 (13.47) | 229.93 (16.69) | 38.07 (3.57)b | 3.75 (0.92)a,b | 1.63 (0.26)a |
I: control group; II: CCl4 induced hepatotoxicity group; III: Silymarin treated group; IV and V: Tamarindus indica L. tablets treated groups at doses 100 mg/kg and 200 mg/kg, respectively.
Different letters on columns indicate significant statistical differences (p < 0.05).